12 results
424B4
BHVN
Biohaven Ltd.
24 Oct 22
Prospectus supplement with pricing info
9:38am
, and we may be held liable for injuries sustained as a result. Any of these factors could cause a delay or termination of preclinical studies, clinical
S-1/A
BHVN
Biohaven Ltd.
20 Oct 22
IPO registration (amended)
10:00am
or obtain regulatory approval for the affected product or product candidate, and we may be held liable for injuries sustained as a result. Any
S-1
BHVN
Biohaven Ltd.
18 Oct 22
IPO registration
4:03pm
for injuries sustained as a result. Any of these factors could cause a delay or termination of preclinical studies, clinical trials or regulatory submissions
DRS
BHVN
Biohaven Ltd.
11 Oct 22
Draft registration statement
12:00am
not be able to successfully commercialize or obtain regulatory approval for the affected product or product candidate, and we may be held liable for injuries
10-12B/A
EX-99.1
hzs4qi kk6st
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
h1nripla 7lf9
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
pivb6vnmypr
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-99.1
xe4c8a
24 Aug 22
Registration of securities (amended)
5:03pm
10-12B
EX-99.1
u40bq zxn1dayo41o2ug
10 Aug 22
Registration of securities
5:07pm
10-12B
EX-2.3
jiic39nt 8yaj
10 Aug 22
Registration of securities
5:07pm
DRS
EX-99.1
5vdxed 4g7ek
1 Jul 22
Draft registration statement
12:00am
- Prev
- 1
- Next